AAPG
Price
$24.30
Change
+$0.97 (+4.16%)
Updated
Feb 4, 12:24 PM (EDT)
Capitalization
2.2B
56 days until earnings call
Intraday BUY SELL Signals
ZLAB
Price
$16.89
Change
+$0.47 (+2.86%)
Updated
Feb 4, 03:29 PM (EDT)
Capitalization
1.86B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AAPG vs ZLAB

Header iconAAPG vs ZLAB Comparison
Open Charts AAPG vs ZLABBanner chart's image
Ascentage Pharma Group
Price$24.30
Change+$0.97 (+4.16%)
Volume$100
Capitalization2.2B
Zai Lab
Price$16.89
Change+$0.47 (+2.86%)
Volume$600
Capitalization1.86B
AAPG vs ZLAB Comparison Chart in %
AAPG
Daily Signal:
Gain/Loss:
ZLAB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AAPG vs. ZLAB commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAPG is a Hold and ZLAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (AAPG: $23.33 vs. ZLAB: $16.43)
Brand notoriety: AAPG and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAPG: 70% vs. ZLAB: 99%
Market capitalization -- AAPG: $2.2B vs. ZLAB: $1.86B
AAPG [@Biotechnology] is valued at $2.2B. ZLAB’s [@Biotechnology] market capitalization is $1.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAPG’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 1 green FA rating(s).

  • AAPG’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 1 green, 4 red.
According to our system of comparison, ZLAB is a better buy in the long-term than AAPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAPG’s TA Score shows that 2 TA indicator(s) are bullish while ZLAB’s TA Score has 5 bullish TA indicator(s).

  • AAPG’s TA Score: 2 bullish, 4 bearish.
  • ZLAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZLAB is a better buy in the short-term than AAPG.

Price Growth

AAPG (@Biotechnology) experienced а -8.83% price change this week, while ZLAB (@Biotechnology) price change was -3.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

AAPG is expected to report earnings on Apr 01, 2026.

ZLAB is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAPG($2.2B) has a higher market cap than ZLAB($1.86B). ZLAB YTD gains are higher at: -6.859 vs. AAPG (-11.090). ZLAB has higher annual earnings (EBITDA): -187.93M vs. AAPG (-1.09B). AAPG has more cash in the bank: 1.66B vs. ZLAB (717M). ZLAB has less debt than AAPG: ZLAB (219M) vs AAPG (1.72B). ZLAB has higher revenues than AAPG: ZLAB (442M) vs AAPG (391M).
AAPGZLABAAPG / ZLAB
Capitalization2.2B1.86B118%
EBITDA-1.09B-187.93M577%
Gain YTD-11.090-6.859162%
P/E RatioN/AN/A-
Revenue391M442M88%
Total Cash1.66B717M232%
Total Debt1.72B219M784%
FUNDAMENTALS RATINGS
ZLAB: Fundamental Ratings
ZLAB
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AAPGZLAB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AAPG
Daily Signal:
Gain/Loss:
ZLAB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMUHX25.220.36
+1.45%
MFS Utilities R3
JDDVX13.75-0.04
-0.29%
Janus Henderson U.S. Dividend Income D
EDICX12.02-0.08
-0.66%
Eaton Vance Global Income Builder C
TWBIX21.27-0.16
-0.75%
American Century Balanced Inv
OTCKX28.00-0.37
-1.30%
MFS Mid Cap Growth R6

AAPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAPG has been loosely correlated with ZLAB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AAPG jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAPG
1D Price
Change %
AAPG100%
+0.69%
ZLAB - AAPG
45%
Loosely correlated
+0.80%
ONC - AAPG
38%
Loosely correlated
+0.40%
PRTC - AAPG
31%
Poorly correlated
+0.59%
ORIC - AAPG
27%
Poorly correlated
-1.43%
ALZN - AAPG
24%
Poorly correlated
-3.69%
More

ZLAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been loosely correlated with ONC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLAB jumps, then ONC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
+0.80%
ONC - ZLAB
55%
Loosely correlated
+0.40%
AAPG - ZLAB
45%
Loosely correlated
+0.69%
BMRN - ZLAB
37%
Loosely correlated
-0.59%
RXRX - ZLAB
36%
Loosely correlated
-1.91%
IRON - ZLAB
35%
Loosely correlated
-1.17%
More